To enroll in 3 months online/correspondence certification course in 'Integrated Medicine', CLICK HERE Stopprescribingatimalariadrug - Dr. Biswaroop Roy Chowdhury

Dr. Biswaroop’s appeal to Govt of India


Topic: Stop prescribing Anti-Malaria drug

With reference to Ministry of Health & Family Welfare &  Directorate General of Health Services (EMR Division) the guideline on Clinical Management of COVID-19 as is displayed in “” as on 20th April – 2020, it recommends the following medicine for the treatment and prevention of COVID-19

1)   Hydroxychloroquine in combination with Azithromycin  as treatment


2) Hydroxychloroquine for Prevention of COVID-19

 The use of the above anti malarial drugs for the treatment of COVID-19 should be halted with immediate effect because of the following references:

  1. There is insufficient evidence to determine whether Hydroxychloroquine are safe and effective treatment for COVID-19
  2. CloroCovid 19 study (clinical trial started on 23rd March 2020 aimed to finish on 31st August 2020, was halted prematurely because of potential safety hazards.
  3. Guwahati doctor Dr Utpal Barman, 44yr old on HCQ(hydroxychloroquine) died of cardiac arrest on 28th March 2020. He was on Hydroxychloroquine as a preventive medication.   Reference Link 1 Reference link  2 & Reference link 3
  4. According to ACC, 29th March 2020 HCQ- Azithromycin treatment in COVID-19 may cause Ventricular Arrhythmia, increasing the mortality risk.
  5.  According to the study “ a retrospective analysis on outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19 “  posted April 23, 2020, the rate of death in hydroxychloroquine, hyroxychloroquine with azithromycin   and no hydroxychloroquine groups were 27.8%, 22.1% and 11.4% respectively